Combination Oral Contraceptive Use and the Risk of Endometrial Cancer

JAMA: The Journal of the American Medical Association

Volumn 257, Issue 6, 1987, Pages 796-800

 

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; ETYNODIOL DIACETATE; GESTAGEN; MESTRANOL; NORETHISTERONE; NORETYNODREL; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADVERSE DRUG REACTION; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DRUG MIXTURE; DRUG THERAPY; ENDOMETRIUM CANCER; FEMALE GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PREVENTION; PRIORITY JOURNAL; THERAPY;

ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CONTRACEPTIVES, ORAL, COMBINED; EPIDEMIOLOGIC METHODS; FEMALE; HUMAN; INFERTILITY, FEMALE; MIDDLE AGE; NATIONAL INSTITUTES OF HEALTH (U.S.); PARITY; QUESTIONNAIRES; RISK; SUPPORT, U.S. GOV'T, P.H.S.; UNITED STATES; UTERINE NEOPLASMS;

EID: 0023155215     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1987.03390060086029     Document Type: Article

References (32)

1. Kelsey JL, LiVolsi VA, Holford TR, et al.: A case-control study of cancer of the endometrium. Am J Epidemiol 1982;116:333-342.
2. Henderson BE, Casagrande JT, Pike MC, et al.: The epidemiology of endometrial cancer in young women. Br J Cancer 1983;47:749-756.
3. Hulka BS, Chambless LE, Kaufman DG, et al.: Protection against endometrial carcinoma by combination-product oral contraceptives. JAMA 1982; 247:475-477.
4. Kaufman DW, Shapiro S, Slone D, et al.: Decreased risk of endometrial cancer among oral contraceptive users. N Engl J Med 1980;303:1045-1047.
5. Weiss NS, Sayvetz TA: Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med 1980;302:551-554.
6. Kay CR: Progestogens before and after the menopause. Br Med J 1980;281:811-812.
7. Ramcharan S, Pellegrin FA, Ray R, et al.: The Walnut Creek Contraceptive Drug Study: A Prospective Study of the Side Effects of Oral Contraceptives, publication (NIH) 81-564. Bethesda, Md, National Institute of Child Health and Human Development, Center for Population Research, 1981, vol 3.
8. The Centers for Disease Control Cancer and Steroid Hormone Study: Oral contraceptive use and the risk of endometrial cancer. JAMA 1983; 249:1600-1604.
9. Trapido EJ: A prospective cohort study of oral contraceptives and cancer of the endometrium. Int J Epidemiol 1983;12:297-300.
10. Horwitz RI, Feinstein AR: Case-control study of oral contraceptive pills and endometrial cancer. Ann Intern Med 1979;91:226-227.
11. The Centers for Disease Control Cancer and Steroid Hormone Study: Long-term oral contraceptive use and the risk of breast cancer. JAMA 1983;249:1591-1595.
12. Stadel BV, Rubin GL, Webster LA, et al.: Oral contraceptives and breast cancer in young women. Lancet 1985;2:970-973.
13. Hartge P, Brinton LA, Rosenthal JF, et al.: Random digit dialing in selecting a populationbased control group. Am J Epidemiol 1984;120: 825-833.
14. Davies JL, Rosenshein NB, Antunes CMF, et al.: A review of the risk factors for endometrial carcinoma. Obstet Gynecol Surv 1981;36:107-116.
15. Elwood JM, Cole P, Rothman KJ, et al.: Epidemiology of endometrial cancer. JNCI 1977;59: 1055-1060.
16. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959;22:719-748.
17. Schlesselman JJ: Case-Control Studies: Design, Conduct, Analysis. New York, Oxford University Press, 1982.
18. Young JL, Percy CL, Asire AJ, et al.: Cancer Incidence and Mortality in the United States, 1973-77, monograph 57. Bethesda, Md, National Cancer Institute, 1984.
19. Ory HW, Forrest JD, Lincoln R: Making Choices. New York, Alan Guttmacher Institute, 1983.
20. Coulter A, Vessey M, McPherson K: The ability of women to recall their oral contraceptive histories. Contraception 1986;33:127-137.
21. Rosenberg MJ, Layde PM, Ory HW, et al.: Agreement between women’s histories of oral contraceptive use and physician records. Int J Epidemiol 1983;12:84-87.
22. Bhagavan BS, Parmley TH, Rosenshein NB, et al.: Comparison of estrogen-induced hyperplasia to endometrial carcinoma. Obstet Gynecol 1984;64: 12-15.
23. Horwitz RI, Feinstein AR, Vidone RA, et al.: Histopathologic distinctions in the relationship of estrogens and endometrial cancer. JAMA 1981; 246:1425-1427.
24. Gordon J, Reagan JW, Finkle WD, et al.: Estrogens and endometrial carcinoma: An independent pathology review supporting original risk estimate. N Engl J Med 1977;297:570-571.
25. Silverberg SG, Makowski EL: Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol 1975;46:503-506.
26. Cohen CJ, Deppe G: Endometrial carcinoma and oral contraceptive agents. Obstet Gynecol 1977;49:390-392.
27. Brinton LA: The relationship of exogenous estrogens to cancer risk. Cancer Detect Prev 1984;7: 159-171.
28. Whitehead MI, Townsend PT, Pryse-Davies J, et al.: Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 1981;305:1599-1605.
29. Maugh TH: Chemical carcinogenesis: A long-neglected field blossoms. Science 1974;183:940-944.
30. Moolgavkar SH, Day NE, Stevens RG: Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. JNCI 1980;65:559-569.
31. Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention. Philadelphia, WB Saunders Co, 1982.
32. Austin DF, Roe KM: The decreasing incidence of endometrial cancer: Public health implications. Am J Public Health 1982;72:65-68.